| scholarly article | Q13442814 |
| P50 | author | Giuliano Pillolla | Q30505128 |
| P2093 | author name string | Anna Lisa Muntoni | |
| Marco Pistis | |||
| Miriam Melis | |||
| Gian Luigi Gessa | |||
| Simona Perra | |||
| P2860 | cites work | Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons | Q24313279 |
| Two types of neurone in the rat ventral tegmental area and their synaptic inputs | Q24531393 | ||
| The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication | Q24651338 | ||
| Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds | Q28294909 | ||
| The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) | Q28343961 | ||
| Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens | Q28346456 | ||
| Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons | Q28363375 | ||
| Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide | Q28370516 | ||
| Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata | Q28377147 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Predictive reward signal of dopamine neurons | Q29615397 | ||
| Structural determinants for recognition and translocation by the anandamide transporter | Q33861497 | ||
| Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices | Q33865224 | ||
| Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol | Q33902321 | ||
| The endocannabinoid system as a target for therapeutic drugs. | Q33934278 | ||
| Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
| Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons | Q33949219 | ||
| Neurobiology of addiction | Q34390258 | ||
| Functional role of high-affinity anandamide transport, as revealed by selective inhibition | Q34436019 | ||
| Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. | Q34543525 | ||
| Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures | Q48963650 | ||
| Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. | Q49115644 | ||
| Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. | Q52026566 | ||
| Modulation of long-term depression by dopamine in the mesolimbic system. | Q52166599 | ||
| Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. | Q52277642 | ||
| Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro | Q60727965 | ||
| Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro | Q61169045 | ||
| Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices | Q67948224 | ||
| Quantal mechanism of neural transmitter release | Q68625734 | ||
| Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo | Q69713840 | ||
| Paired-pulse modulation of fast excitatory synaptic currents in microcultures of rat hippocampal neurons | Q70917625 | ||
| Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand | Q71040771 | ||
| Increased probability of GABA release during withdrawal from morphine | Q71955013 | ||
| Cortical Regulation of Subcortical Dopamine Release: Mediation via the Ventral Tegmental Area | Q71978525 | ||
| Anandamide: an endogenous activator of the vanilloid receptor | Q73599870 | ||
| Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor | Q73704501 | ||
| Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors | Q74061522 | ||
| Burst firing in midbrain dopaminergic neurons | Q74293267 | ||
| Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid | Q77725799 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Transient changes in mesolimbic dopamine and their association with 'reward'. | Q34928934 | ||
| The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. | Q35040754 | ||
| Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia | Q36500321 | ||
| Presynaptic specificity of endocannabinoid signaling in the hippocampus | Q39750122 | ||
| Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse | Q39897578 | ||
| Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. | Q40552011 | ||
| The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism | Q40817229 | ||
| Dopamine neurons and their role in reward mechanisms | Q40899058 | ||
| Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. | Q41650647 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Activation of cAMP-dependent protein kinase suppresses the presynaptic cannabinoid inhibition of glutamatergic transmission at corticostriatal synapses | Q42517690 | ||
| Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons | Q43038646 | ||
| Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease | Q43504648 | ||
| The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase | Q43512138 | ||
| Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals | Q43574291 | ||
| Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors | Q43715218 | ||
| Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca(2+) influx in Purkinje cells | Q43768752 | ||
| Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. | Q43816494 | ||
| Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. | Q43918814 | ||
| Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation | Q43936608 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study | Q43991315 | ||
| Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. | Q43999138 | ||
| Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 | ||
| Cannabinoid-induced Fos expression within A10 dopaminergic neurons | Q44298237 | ||
| Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area | Q44345598 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum | Q44385248 | ||
| Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. | Q44397933 | ||
| Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors | Q44418969 | ||
| Neuromorphological background of cannabis addiction | Q44494962 | ||
| Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus | Q44511960 | ||
| Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses | Q46533972 | ||
| Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump | Q47931189 | ||
| Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra. | Q48153418 | ||
| Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal | Q48157165 | ||
| Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids | Q48192488 | ||
| Purification and characterization of two immunologically distinct phosphoinositide-specific phospholipases C from bovine brain | Q48207068 | ||
| Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo | Q48249875 | ||
| Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. | Q48251433 | ||
| Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action | Q48309971 | ||
| Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. | Q48452719 | ||
| Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. | Q48455941 | ||
| Cannabinoid receptors and their endogenous agonists | Q48464429 | ||
| Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area | Q48469772 | ||
| Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area | Q48495452 | ||
| Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
| Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. | Q48568603 | ||
| Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum | Q48581988 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| endocannabinoids | Q10483908 | ||
| P304 | page(s) | 53-62 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors | |
| P478 | volume | 24 |
| Q38036236 | A brain on cannabinoids: the role of dopamine release in reward seeking |
| Q46765854 | Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
| Q37408145 | Adaptations of striatal endocannabinoid system during stress. |
| Q52308392 | Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex. |
| Q37164808 | Advances in the field of cannabinoid--opioid cross-talk |
| Q33975305 | Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs. |
| Q41760767 | Altered Mesolimbic Dopamine System in THC Dependence |
| Q37568611 | Anandamide receptor signal transduction |
| Q37015433 | Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats |
| Q33901801 | Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents? |
| Q37444802 | Basic neuroanatomy and neuropharmacology of cannabinoids |
| Q34676610 | Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? |
| Q90524726 | Brain activity of anandamide: a rewarding bliss? |
| Q41903743 | CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice |
| Q36436842 | CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats |
| Q47643855 | CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana. |
| Q35593070 | COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation |
| Q34053352 | Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice |
| Q37444808 | Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders |
| Q42136572 | Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization |
| Q46471752 | Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats |
| Q37568626 | Cannabinoid receptor CB1 antagonists state of the art and challenges. |
| Q30576216 | Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release |
| Q42872711 | Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. |
| Q50433366 | Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates |
| Q37308607 | Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
| Q34992139 | Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q38522769 | Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia |
| Q21090468 | Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far |
| Q33819365 | Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. |
| Q36393644 | Cannabinoids and value-based decision making: implications for neurodegenerative disorders. |
| Q46932814 | Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. |
| Q44885114 | Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. |
| Q48180728 | Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal |
| Q42258332 | Cannabinoids in Parkinson's Disease |
| Q45153962 | Cannabinoids--signal transduction and mode of action |
| Q36757474 | Cannabis cue-elicited craving and the reward neurocircuitry |
| Q37160448 | Cannabis, cannabinoids and schizophrenia: integration of the evidence |
| Q64285404 | Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells |
| Q45814311 | Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling. |
| Q48463767 | Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats |
| Q45138733 | Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. |
| Q27320220 | Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area |
| Q38103533 | Cocaine-evoked synaptic plasticity of excitatory transmission in the ventral tegmental area. |
| Q83227323 | Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion |
| Q44926074 | Combination of rimonabant and donepezil prolongs spatial memory duration |
| Q35196842 | Contrasting Effects of Lithium Chloride and CB1 Receptor Blockade on Enduring Changes in the Valuation of Reward |
| Q50653781 | Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors. |
| Q34530386 | Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents |
| Q36922736 | Cyclooxygenase-2 in synaptic signaling |
| Q62725703 | Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis |
| Q46716625 | Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones |
| Q46384482 | Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent long-term depression. |
| Q33258602 | Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain |
| Q48422615 | Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats |
| Q44907313 | Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice |
| Q38564008 | Dissecting the cannabinergic control of behavior: The where matters |
| Q46815699 | Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration |
| Q46279749 | Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. |
| Q34001324 | Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex |
| Q34575484 | Drug addiction. |
| Q37310301 | Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions |
| Q41865699 | Effect of Acetaldehyde Intoxication and Withdrawal on NPY Expression: Focus on Endocannabinoidergic System Involvement |
| Q36201313 | Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats |
| Q46011230 | Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats. |
| Q46382591 | Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats |
| Q34359778 | Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell. |
| Q41602438 | Endocannabinoid CB1 receptor-mediated rises in Ca(2+) and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus |
| Q39400299 | Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling |
| Q36954198 | Endocannabinoid liberation from neurons in transsynaptic signaling |
| Q39267685 | Endocannabinoid modulation of dopamine neurotransmission |
| Q36802414 | Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke |
| Q34967151 | Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? |
| Q46767737 | Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. |
| Q46075930 | Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells |
| Q38250054 | Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues |
| Q37363621 | Endocannabinoid-mediated control of synaptic transmission |
| Q29042501 | Endocannabinoid-mediated synaptic plasticity and addiction-related behavior |
| Q93046837 | Endocannabinoids Interact With the Dopaminergic System to Increase Sexual Motivation: Lessons From the Sexual Satiety Phenomenon |
| Q33583792 | Endocannabinoids and striatal function: implications for addiction-related behaviours |
| Q40794240 | Endocannabinoids and the processing of value-related signals |
| Q79374957 | Endocannabinoids in chronic migraine: CSF findings suggest a system failure |
| Q33757950 | Endocannabinoids in the dentate gyrus |
| Q30573498 | Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates |
| Q30504551 | Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum |
| Q37397239 | Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors |
| Q35202878 | Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors |
| Q34197671 | Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats |
| Q40972919 | Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-Like Behavior. |
| Q27687624 | Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs |
| Q42090722 | Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area |
| Q37177970 | Ethanol facilitates glutamatergic transmission to dopamine neurons in the ventral tegmental area |
| Q30478061 | Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation |
| Q38056394 | Functional diversity on synaptic plasticity mediated by endocannabinoids |
| Q50200300 | Functional relevance of endocannabinoid-dependent synaptic plasticity in the CNS. |
| Q24648924 | Glutamatergic substrates of drug addiction and alcoholism |
| Q55346929 | Hedonic Eating and the "Delicious Circle": From Lipid-Derived Mediators to Brain Dopamine and Back. |
| Q24623244 | Hub and switches: endocannabinoid signalling in midbrain dopamine neurons |
| Q36452302 | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
| Q91577885 | In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis |
| Q46460331 | In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol |
| Q36873051 | Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. |
| Q28283718 | Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction |
| Q37146387 | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats |
| Q30581737 | Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids |
| Q38686274 | Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives |
| Q38203030 | Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction |
| Q35121789 | Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats |
| Q46755929 | Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo |
| Q36587189 | Lipid signaling and synaptic plasticity |
| Q37533064 | Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor-Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators |
| Q24671514 | Marijuana and cannabinoid regulation of brain reward circuits |
| Q37969448 | Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. |
| Q39635726 | Measurement of Inverse Agonism of the Cannabinoid Receptors |
| Q48255013 | Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo |
| Q48367782 | Metabotropic suppression of excitation in murine autaptic hippocampal neurons |
| Q43100078 | Metaplasticity of hypothalamic synapses following in vivo challenge |
| Q33923685 | Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells |
| Q38358456 | Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems |
| Q37444504 | Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons |
| Q28244889 | N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors |
| Q35626920 | Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers |
| Q41913192 | Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings |
| Q30493991 | Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. |
| Q47725960 | Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus. |
| Q28580090 | Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey |
| Q45763902 | Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area. |
| Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
| Q55255522 | Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons. |
| Q37282359 | Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs. |
| Q36943246 | Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. |
| Q53404854 | Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. |
| Q90248156 | Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders |
| Q30360453 | Precondition of right frontal region with anodal tDCS can restore the fear memory impairment induced by ACPA in male mice. |
| Q45163158 | Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. |
| Q46504765 | Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons. |
| Q37082410 | Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors |
| Q47645331 | Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities |
| Q37495511 | Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self-Administration by Wistar Rats. |
| Q43055373 | Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons |
| Q33599036 | Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes |
| Q38697025 | Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia. |
| Q35216481 | Role of the endogenous cannabinoid system in nicotine addiction: novel insights |
| Q37402537 | Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats |
| Q46424750 | Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris). |
| Q37529127 | Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure |
| Q37867227 | Supply and demand for endocannabinoids |
| Q36358712 | Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate |
| Q28476578 | Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning |
| Q37040227 | Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. |
| Q41489097 | THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. |
| Q38126265 | Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? |
| Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
| Q50226059 | The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. |
| Q38974429 | The Role of Cannabinoid Receptors in the Descending Modulation of Pain |
| Q36176513 | The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats |
| Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
| Q36083476 | The dopamine hypothesis of drug addiction: hypodopaminergic state. |
| Q42485353 | The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice |
| Q35989527 | The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q36741861 | The endocannabinoid system in brain reward processes |
| Q37291517 | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. |
| Q37142237 | The endocannabinoid system: emotion, learning and addiction |
| Q21090144 | The mechanistic classification of addictive drugs |
| Q41967071 | The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area |
| Q26770739 | To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making |
| Q36265810 | Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements |
| Q92972277 | Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood |
| Q48608696 | Why sigma-1 receptor dysfunction might confer vulnerability to cannabis-induced psychosis |
| Q33771857 | mGluR-mediated and endocannabinoid-dependent long-term depression in the hilar region of the rat dentate gyrus |
| Q90263815 | Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation |
| Q36905084 | α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors |
Search more.